Picture of Yunkang logo

2325 Yunkang Income Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapContrarian

Annual income statement for Yunkang, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1,6973,756892712601
Cost of Revenue
Gross Profit8991,308326211183
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses1,2393,2989441,464568
Operating Profit458459-52.6-75232.9
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes451443-86.8-7916.97
Provision for Income Taxes
Net Income After Taxes372374-102-7933.9
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income381377-102-7922.92
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income381377-102-7922.92
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.6051.11-0.169-1.3-0.232
Dividends per Share